Scientists develop new treatments for Alzheimer's diseaseOctober 27, 2006Scientists at the University of Liverpool have created a new chemical compound that could be developed into a drug treatment for Alzheimer's disease. The research team has used a family of long chain sugars called Heparan Sulphates (HS), found on nearly every cell of the body, to produce a new compound that can prevent the formation of clumps of small proteins that form in the brain. These clumps or 'plaques' disrupt the normal function of cells leading to progressive memory loss which is characteristic of Alzheimer's disease. The clumps are formed from a small protein fragment called Amyloid-beta (A-beta) peptide released from its 'parent' protein-amyloid precursor protein (APP). This process requires the action of an enzyme called beta-secetase (BACE), which is critical in clipping up the APP to form the smaller A-beta fragments. Professor Jerry Turnbull and Dr Ed Yates, from the University's School of Biological Sciences, have discovered that the HS sugars may play a key role in limiting the development of Alzheimer's disease. The sugars stick to the BACE enzyme and reduce its ability to 'clip' the A-beta peptide, thus controlling the amount of A-beta peptide available to form damaging plaques in brain tissue. Professor Turnbull said: "We have developed a new class of compounds called 'engineered heparins' that could possibly be developed into drugs to stop A-beta peptides in the brain from forming and for the first time treat the underlying cause of Alzheimer's. The compound, based on the blood thinning drug, heparin, has modified chemical structures designed to optimise their desired activities and reduce potential side effects. "The compounds work by blocking the beta-secretase enzyme, responsible for snipping proteins into smaller fragments. Despite its central importance to the disease, there are currently no drug treatments which target this enzyme because it has proved difficult to find inhibitors using traditional drug discovery approaches. The new compounds, based on the body's natural substances, may provide a novel route to effective treatments for this debilitating disease.\\\ University of Liverpool |
|||||||||||||||||||||
| Related Alzheimers Disease Current Events and Alzheimers Disease News Articles Cold sore virus might play role in Alzheimer's disease A gene known to be a major risk factor for Alzheimer's disease puts out the welcome mat for the virus that causes cold sores, allowing the virus to be more active in the brain compared to other forms of the gene. Study offers window into human behavior, brain disease UCSF scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia, which is as common as Alzheimer's disease in patients who develop dementia before age 65. New imaging compound might 'see' Alzheimer's earlier A new imaging molecule that can detect and map plaques and tangles in the brains of people with Alzheimer's disease could eventually lead to earlier diagnosis of the devastating disease, researchers at the University of California, Los Angeles report in the Dec. 21, 2006, issue of the New England Journal of Medicine. Testosterone therapy may prevent Alzheimer's disease Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease. Androgen therapy may slow progress of Alzheimer's disease Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression. Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease. Study shows cats can succumb to feline Alzheimer's disease Ageing cats can develop a feline form of Alzheimer's disease, a new study reveals. Scientists at the Universities of Edinburgh, St Andrews, Bristol and California have identified a key protein which can build up in the nerve cells of a cat's brain and cause mental deterioration. Scientists develop a new way to target Alzheimer's disease The pathological embrace between two proteins plays a key role in the development of Alzheimer's disease by triggering the formation of neuron-killing plaques of amyloid beta protein. Now a group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins. Complaints About Memory Are Associated With Alzheimer-Related Brain Damage Researchers at Rush University Medical Center found that having complaints about memory problems is associated with changes in the brain related to Alzheimer's disease. They reported their findings in the November 2006 issue of Neurology. More insight into Alzheimer's disease with Stanford discovery of possible cause A peacekeeper in the body's defenses against infection may hold the key to understanding-and eventually treating-Alzheimer's disease. Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease. More Alzheimers Disease Current Events and Alzheimers Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||